James Chih Hsin Yang

Statistics

Publications

Citations

424

H-Index

Active since

2022

Affiliations

Asan Medical Center(Current)

James Chih Hsin Yang is an author at Asan Medical Center specializing in atezolizumab therapy, combination cancer therapy, and lung cancer pharmacotherapy.

Publications per year

2022–2022

Publications

Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study

Byoung Chul Cho, Delvys Rodríguez‐Abreu, Maen Hussein et al. · The Lancet Oncology · 2022 · 424 citations · Full text

Medicine, Oncology, Pharmacology +14

1–1 of 1